Wall Street analysts polled by Zacks Research have given CONMED Corporation (NASDAQ:CNMD) a rating of 2 on a consensus basis. Using a simplified scale where 1 is a Strong Buy and 5 a Strong Sell, this is the average number of the 6 brokerages surveyed. The stock had a rating of 2 when analyst ratings were averaged three months ago.
The covering analysts have a one year price objective of $59 on CONMED Corporation (NASDAQ:CNMD). The most bullish brokerage firm sees the stock heading to $65 , while the most conservative estimate has an objective of $51.
Earnings Look
Wall Street will be paying close attention when CONMED Corporation reports their next quarterly earnings report on 2015-07-21. Analysts polled by Zacks are expecting earnings per share of $0.43 for the period ending 2015-06-30. This is the consensus number based on the 6 broker predictions taken into consideration. On a longer term basis, sell-side analysts who project long term growth are expecting earnings of $15. This is the three to five year estimate for both earnings and sales.
Most recently CONMED Corporation reported actual earnings of $0.42 per share for the quarter ending on 2015-03-31. The actual reported number was $0.01 away from what analysts had expected, yielding a surprise factor of 2.44%.
CONMED Corporation (CONMED) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care. The Company offers a range of devices and products for uses in arthroscopic surgery. The Company’s powered instruments product line includes the MPower battery system. The Company’s patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs.
